aspirin has been researched along with tamoxifen in 44 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (18.18) | 18.2507 |
| 2000's | 10 (22.73) | 29.6817 |
| 2010's | 23 (52.27) | 24.3611 |
| 2020's | 3 (6.82) | 2.80 |
| Authors | Studies |
|---|---|
| Gust, R; Kircher, B; Ott, I; Schmidt, K; Schumacher, P; Wiglenda, T | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Bharate, SS; Vishwakarma, RA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Buzaid, AC; Durivage, HJ; Murren, JR | 1 |
| du Plessis, DJ; van Aswegen, CH; Viljoen, TC | 1 |
| Abecassis, J; Cutuli, B; Fricker, JP; Petit, JC; Schumacher, C; Velten, M | 1 |
| Kardinal, CG | 1 |
| Collins, R; Gray, R; Peto, R | 1 |
| Garattini, S; La Vecchia, C; Tavani, A | 1 |
| Berry, SM | 1 |
| Lush, DT | 1 |
| Sharma, RA | 1 |
| Gescher, AJ; O'Byrne, KJ; Sharma, RA; Steward, WP | 1 |
| Chen, YZ; Ung, CY | 1 |
| Liu, SH; Tsai, KS; Yang, RS | 1 |
| Hampton, T | 1 |
| Holmes, CE; Howard, AB; Huang, JC; Muss, HB; Pace, TR | 1 |
| Chamani, JK; Pourgonabadi, S; Saberi, MR | 1 |
| Harrington, M | 1 |
| Holmes, CE; Jasielec, J; Levis, JE; Muss, HB; Skelly, J | 1 |
| Frank, J; Podszun, M | 1 |
| Ch Yiannakopoulou, E | 1 |
| Cuzick, J; Sestak, I | 1 |
| Cao, Y; Chen, H; Tang, W; Zhang, H; Zhang, Z | 1 |
| Cheng, R; Cui, JW; Fang, ZY; Li, P; Li, YX; Liu, XL; Liu, YJ; Lu, SY; Wang, Z; Wei, W; Wu, XQ; Yang, M; Zhou, Y; Zhu, LZ; Zou, L | 1 |
| Cuzick, J | 1 |
| Ahern, TP; Christiansen, P; Cronin-Fenton, D; Damkier, P; Ejlertsen, B; Lash, TL; Sørensen, HT | 1 |
| Ahmed, MR; Ahmed, WAS; Aref, NK; Sedik, WF | 1 |
| Correia, MA; Jacob, P; Kim, SM; Kwon, D; Liu, Y | 1 |
| Burov, SV; Haq, S; Harless, W; Markvicheva, E; Qorri, B; Sambi, M; Samuel, V; Szewczuk, MR | 1 |
| Choulerton, J; Guha, N; Squires, R | 1 |
| Arnachellen, D; Augustine, TN; Pillay, K; Xulu, KR | 1 |
10 review(s) available for aspirin and tamoxifen
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Large-scale randomized evidence: large, simple trials and overviews of trials.
Topics: Aspirin; Bias; Breast Neoplasms; Cardiovascular Diseases; Effect Modifier, Epidemiologic; Female; Fibrinolytic Agents; Health Services Research; Humans; Magnesium; Male; Meta-Analysis as Topic; Middle Aged; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Factors; Survival Rate; Tamoxifen | 1993 |
Adverse effects of preventive therapy in humans.
Topics: Anticarcinogenic Agents; Aspirin; Contraceptives, Oral; Humans; Neoplasms; Retinoids; Tamoxifen | 1996 |
Preventing heart disease and cancer. What randomized, primary-prevention studies show.
Topics: Aged; Antineoplastic Agents; Aspirin; Breast Neoplasms; Coronary Disease; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Primary Prevention; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selenium; Tamoxifen; Vitamin E | 1999 |
Cancer chemoprevention: a clinical reality.
Topics: Antineoplastic Agents, Hormonal; Aspirin; Breast Neoplasms; Chemoprevention; Colorectal Neoplasms; Cyclooxygenase Inhibitors; Female; Humans; Tamoxifen | 2000 |
Familiar drugs may prevent cancer.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticarcinogenic Agents; Aspirin; Celecoxib; Cyclooxygenase Inhibitors; Female; Folic Acid; Humans; Male; Neoplasms; Pyrazoles; Raloxifene Hydrochloride; Sulfonamides; Tamoxifen; Vitamin A | 2001 |
Vitamin E-drug interactions: molecular basis and clinical relevance.
Topics: Animals; Aspirin; Cyclosporine; Dietary Supplements; Dose-Response Relationship, Drug; Drug Interactions; Humans; Tamoxifen; Vitamin E; Warfarin | 2014 |
Interaction of Salicylates and the Other Nonsteroidal Anti-Inflammatory Agents With Breast Cancer Endocrine Treatment: Systematic Review.
Topics: Androstadienes; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Aspirin; Breast Neoplasms; Celecoxib; Drug Synergism; Female; Humans; Salicylates; Tamoxifen | 2015 |
Update on breast cancer risk prediction and prevention.
Topics: Age of Onset; Aromatase Inhibitors; Aspirin; Biomarkers, Tumor; Breast Neoplasms; Diphosphonates; Female; Humans; Metformin; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Selective Estrogen Receptor Modulators; Tamoxifen; Treatment Outcome | 2015 |
Preventive therapy for cancer.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aromatase Inhibitors; Aspirin; Chemoprevention; Colectomy; Contraceptives, Oral; Diet; Estrogen Antagonists; Hepatitis B Vaccines; Humans; Neoplasms; Ovariectomy; Papillomavirus Vaccines; Prophylactic Mastectomy; Tamoxifen | 2017 |
4 trial(s) available for aspirin and tamoxifen
| Article | Year |
|---|---|
High-dose cisplatin with dacarbazine and tamoxifen in the treatment of metastatic melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Cisplatin; Dacarbazine; Drug Evaluation; Female; Hematologic Diseases; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Remission Induction; Skin Neoplasms; Tamoxifen | 1991 |
Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer.
Topics: Adult; Antineoplastic Agents; Aromatase Inhibitors; Aspirin; Blood Platelets; Breast Neoplasms; Endostatins; Female; Humans; Immunoassay; Middle Aged; Neovascularization, Pathologic; Platelet Aggregation Inhibitors; Selective Estrogen Receptor Modulators; Tamoxifen; Vascular Endothelial Growth Factor A | 2008 |
Initiation of aspirin therapy modulates angiogenic protein levels in women with breast cancer receiving tamoxifen therapy.
Topics: Adult; Aged; Angiogenic Proteins; Aspirin; Blood Platelets; Breast Neoplasms; Female; Humans; Middle Aged; Platelet Activation; Receptors, Thrombin; Tamoxifen; Thrombospondin 1; Vascular Endothelial Growth Factor A | 2013 |
A new look at low-dose aspirin: Co-administration with tamoxifen in ovulation induction in anovulatory PCOS women.
Topics: Adult; Anovulation; Aspirin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Egypt; Endometrium; Female; Fertility Agents, Female; Humans; Infertility, Female; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Tamoxifen; Young Adult | 2019 |
30 other study(ies) available for aspirin and tamoxifen
| Article | Year |
|---|---|
Antitumor-active cobalt-alkyne complexes derived from acetylsalicylic acid: studies on the mode of drug action.
Topics: Alkynes; Antineoplastic Agents; Apoptosis; Aspirin; Cell Line, Tumor; Cell Nucleus; Cobalt; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; DNA; Drug Screening Assays, Antitumor; Enzyme-Linked Immunosorbent Assay; Humans; Membrane Proteins; Organometallic Compounds; Prostaglandin-Endoperoxide Synthases | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Binding of estradiol to whole prostatic DU-145 cells in the presence and absence of tamoxifen and acetylsalicylic acid.
Topics: Aspirin; Binding, Competitive; Cytoplasm; Diethylstilbestrol; Dihydrotestosterone; Estradiol; Estrogen Antagonists; Estrogens, Non-Steroidal; Humans; Immunohistochemistry; Male; Prostatic Neoplasms; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured | 1995 |
[Thromboembolic accidents in postmenopausal patients with adjuvant treatment by tamoxifen. Frequency, risk factors and prevention possibilities].
Topics: Aged; Aged, 80 and over; Aspirin; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Hemostasis; Humans; Middle Aged; Postmenopause; Risk Factors; Tamoxifen; Thromboembolism; Time Factors | 1995 |
Cancer. A potentially preventable disease.
Topics: Aspirin; Environmental Exposure; Female; Finasteride; Humans; Isotretinoin; Life Style; Male; Middle Aged; Neoplasms; Risk Factors; Tamoxifen | 1995 |
Understanding and testing for heterogeneity across 2 x 2 tables: application to meta-analysis.
Topics: Antineoplastic Agents, Hormonal; Aspirin; Bayes Theorem; Breast Neoplasms; Humans; Meta-Analysis as Topic; Models, Statistical; Myocardial Infarction; Tamoxifen | 1998 |
Prediction of potential toxicity and side effect protein targets of a small molecule by a ligand-protein inverse docking approach.
Topics: Ascorbic Acid; Aspirin; Computer Simulation; Drug-Related Side Effects and Adverse Reactions; Gentamicins; Ibuprofen; Indinavir; Ligands; Models, Molecular; Molecular Structure; Neomycin; Penicillin G; Pharmaceutical Preparations; Proteins; Software; Tamoxifen | 2001 |
Benzo[a]pyrene regulates osteoblast proliferation through an estrogen receptor-related cyclooxygenase-2 pathway.
Topics: Animals; Aspirin; Benzo(a)pyrene; Benzoflavones; Cell Division; Cells, Cultured; Cyclooxygenase 2; Enzyme Inhibitors; Humans; Isoenzymes; MAP Kinase Signaling System; Membrane Proteins; Mitogen-Activated Protein Kinases; Osteoblasts; Phosphoinositide-3 Kinase Inhibitors; Prostaglandin-Endoperoxide Synthases; Prostaglandins E; Rats; Receptors, Aryl Hydrocarbon; Receptors, Estrogen; Tamoxifen | 2004 |
Aspirin may protect against breast cancer. But tamoxifen and mastectomy are still the only proven preventatives, though other approaches are under study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Aspirin; Breast Neoplasms; Female; Humans; Tamoxifen | 2004 |
Clinical trials point to complexities of chemoprevention for cancer.
Topics: Aspirin; Breast Neoplasms; Clinical Trials as Topic; Diet; Dihydrotestosterone; Female; Finasteride; Humans; Male; Neoplasms; Prostatic Neoplasms; Selective Estrogen Receptor Modulators; Tamoxifen; Vitamin E | 2005 |
Investigating the antagonistic action between aspirin and tamoxifen with HSA: identification of binding sites in binary and ternary drug-protein systems by spectroscopic and molecular modeling approaches.
Topics: Aspirin; Binding Sites; Drug Antagonism; Humans; Models, Molecular; Protein Binding; Protein Conformation; Serum Albumin; Spectrum Analysis; Tamoxifen | 2011 |
An aspirin a day keeps cancer at bay?
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aspirin; Cell Line, Tumor; Cell Proliferation; Chemoprevention; Drug Synergism; Female; Mice; Tamoxifen; Triple Negative Breast Neoplasms | 2013 |
Network-based inference methods for drug repositioning.
Topics: Algorithms; Area Under Curve; Aspirin; Computational Biology; Computer Simulation; Databases, Factual; Drug Repositioning; Felodipine; Humans; Models, Statistical; Pharmaceutical Preparations; Predictive Value of Tests; ROC Curve; Software; Tamoxifen | 2015 |
Aspirin regulation of c-myc and cyclinD1 proteins to overcome tamoxifen resistance in estrogen receptor-positive breast cancer cells.
Topics: Antineoplastic Agents, Hormonal; Aspirin; Biomarkers; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Hydroxytestosterones; Proto-Oncogene Proteins c-myc; Receptors, Estrogen; Tamoxifen | 2017 |
Concurrent new drug prescriptions and prognosis of early breast cancer: studies using the Danish Breast Cancer Group clinical database.
Topics: Adrenergic beta-Antagonists; Analgesics, Opioid; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breast Neoplasms; Cardiotonic Agents; Cyclooxygenase 2 Inhibitors; Databases, Factual; Denmark; Digoxin; Disease Progression; Estrogen Antagonists; Female; Glucocorticoids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Neoplasm Recurrence, Local; Platelet Aggregation Inhibitors; Prognosis; Selective Serotonin Reuptake Inhibitors; Simvastatin; Tamoxifen | 2018 |
Induction via Functional Protein Stabilization of Hepatic Cytochromes P450 upon gp78/Autocrine Motility Factor Receptor (AMFR) Ubiquitin E3-Ligase Genetic Ablation in Mice: Therapeutic and Toxicological Relevance.
Topics: Animals; Aspirin; Cells, Cultured; Cytochrome P-450 Enzyme Inducers; Cytochrome P-450 Enzyme System; Enzyme Induction; Gene Deletion; Hepatocytes; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Protein Stability; Receptors, Autocrine Motility Factor; Tamoxifen; Ubiquitin-Protein Ligases | 2019 |
A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer.
Topics: Aldehyde Dehydrogenase 1 Family; Antineoplastic Agents; Apoptosis; Aspirin; Breast Neoplasms; CD24 Antigen; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Hyaluronan Receptors; Metformin; Oseltamivir; Retinal Dehydrogenase; Spheroids, Cellular; Tamoxifen; Triple Negative Breast Neoplasms; Tumor Cells, Cultured | 2020 |
Anabolic steroid use and ischaemic stroke in a young fitness enthusiast.
Topics: Administration, Intravenous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Aspirin; Atorvastatin; Brain Ischemia; Clomiphene; Doping in Sports; Echocardiography; Estrogen Antagonists; Exercise; Heart Septal Defects, Atrial; Humans; Ischemic Stroke; Male; Tamoxifen; Testosterone Congeners | 2021 |
Breast Tumor Cells Evade the Cytotoxic Action of Anastrozole, Aspirin, and Clopidogrel Cocktail.
Topics: Anastrozole; Animals; Antineoplastic Agents; Aspirin; Breast Neoplasms; Clopidogrel; Female; Humans; Mammary Neoplasms, Animal; Nitriles; Tamoxifen; Triazoles | 2023 |